Connection

JOHN KIRKWOOD to Oligonucleotides, Antisense

This is a "connection" page, showing publications JOHN KIRKWOOD has written about Oligonucleotides, Antisense.
Connection Strength

0.309
  1. Oblimersen in the treatment of metastatic melanoma. Future Oncol. 2007 Jun; 3(3):263-71.
    View in: PubMed
    Score: 0.252
  2. Targeted therapy for malignant melanoma. Curr Oncol Rep. 2001 Jul; 3(4):344-52.
    View in: PubMed
    Score: 0.042
  3. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol. 2006 Oct 10; 24(29):4738-45.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.